Trial intelligence / Profile preview

Lopinavir/Ritonavir monotherapy vs combination therapy in HIV/HCV coinfected patients

NCT00437684Phase 3Unknown

Sponsor
IRCCS Ospedale San Raffaele
Start
Feb 2007
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by IRCCS Ospedale San Raffaele. Status: unknown.

02

Drugs

lopinavir + ritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00437684.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00437684.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call